Dependence on Prescription Benzodiazepines and Z-drugs Among Young to Middle-aged Patients in France

REFERENCES

• Agence Française de Sécurité Sanitaire des Produits de Santé & Centres d'Evaluation et d'Information sur les Pharmacodépendance-Addictovigilance (2009). Résultats de l'enquête OSIAP (Ordonnances Suspectes, Indicateurs d'Abus Possible) 2009. Retrieved October 24, 2012. Web site : http://ansm. sante.fr/var/ansm_site/storage/original/application/e3aca65806 f6ca762a5d683b4003cf9f.pdf.
   Google Scholar
• Agence Française de Sécurité Sanitaire des Produits de Santé (Afssaps) (2012). Etats de lieux de la consommation des benzodiazépines en France. Rapport d'expertise. January. http://ansm. sante.fr/var/ansm_site/storage/original/application/3f1dc4756b5 bc091879c9c254d95e05c.pdf
   Google Scholar
• Agence Française de Sécurité Sanitaire des Produits de Santé & Centre d'Evaluation et d'Information sur la Pharmacodependance-Addictovigilance (2012). Programme d'Observation des Pharmacodépendances en Médecine Ambulatoire, OPEMA IV : principaux résultats de l'enquête n°4 (2012). Retrieved December 11, 2012. Web site : http://www. addictovigilance.fr/IMG/pdf/brochure_resultats_no4_version_2. pdf
   Google Scholar
• American Psychiatric Association - DSM-IV-TR (2000). Diagnostic and statistical manual of mental disorders (Fourth edition). Washington DC: APA.
   Google Scholar
• Ashton, H. (2005). The diagnosis and management of benzodiazepine dependence. Current Opinion in Psychiatry, 18(3), 249–255.
   PubMed Web of Science ®Google Scholar
• Barker, M. J., Greenwood, K. M., Jackson, M. & Crowe, S. F. (2004). Persistence of cognitive effects after withdrawal from long term benzodiazepine use: a meta-analysis. Archives of Clinical Neuropsychology, 19(3), 437–454.
   PubMed Web of Science ®Google Scholar
• Busto, U. E., & Sellers, E. M. (1991a). Anxiolytics and sedative/hypnotics dependence. British Journal of Addiction, 86(12), 1647–1652.
   PubMedGoogle Scholar
• Busto, U. E., & Seller, E. M. (1991b). Pharmacologic aspects of benzodiazepine tolerance and dependence. Substance Abuse Treatment, 8(1–2), 29–33.
   PubMedGoogle Scholar
• De las Cuevas, C., Sanz, E., & De La Fuente, J. (2003). Benzodiazepines: more « behavioural » addiction than dependence. Psychopharmacology (Berl), 167(3), 297–303.
   PubMed Web of Science ®Google Scholar
• Fang, S. Y., Chen, C. Y., Chang, I. S., Wu, E. C. H., Chang, C. M., & Lin, K. M. (2009). Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study. Drug and Alcohol Dependence, 104(1–2), 140–146. http://dx.doi.org/10.1016/j.drugalcdep.2009.04. 017.
   PubMedGoogle Scholar
• Guillou-Landreat, M., Victorri-Vigneau, C., Hardouin, J. B., Grall-Bronnec, M., Marais, M., Venisse, J. L., & Jolliet, P. (2010). Can we say that seniors are addicted to benzodiazepines? Substance Use & Misuse, 45(12), 1988–1999. http://dx. doi.org/10.3109/10826081003777568.
   PubMedGoogle Scholar
• Harrison, L. (1997). The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA - Research Monographs, 167, 17–36.
   PubMedGoogle Scholar
• Hulten, R. V., Teeuw, K. B., Bakker, A., & Leufkens, H. G. (2003). Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-up. European Journal of Clinical Pharmacology, 58(10), 689–694. http://dx.doi. org/10.1007/s00228-002-0548-0.
   PubMedGoogle Scholar
• Jeantaud, I., Haramburu, F., & Bégaud, B. (2001). Benzodiazepine consumption: survey of community pharmacies in Aquitaine. Therapie, 56(4), 415–419.
   PubMedGoogle Scholar
• Journal officiel de la république Française. Arrêté du 7 octobre 1991 fixant la liste des substances de la liste 1 des substances vénéneuses à propriétés hypnotique et/ou anxiolytique dont la durée de prescription est réduite. http://www.legifrance. gouv.fr/affichTexte.do?cidTexte=LEGITEXT000020690355 (accessed 24 October 2012).
   Google Scholar
• Journal officiel de la république Française. Arrêté du 28 mars 1997 portant approbation des conventions médicales. Retrieved October 24, 2012. Web site : http://legimobile.fr/fr/lr/jorf/ 1997/3/29/TASS9721163A.
   Google Scholar
• Kalapatapu, R. K., & Sullivan, M. A. (2010). Prescription use disorders in older adults. American Journal on Addictions, 19(6), 515–522. http://dx.doi.org/10.1111/j.1521-0391.2010. 00080.x.
   PubMed Web of Science ®Google Scholar
• Kan, C. C., Breteler, M. H. M., & Zitman, F. G. (1997). High prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R and ICD-10 criteria. Acta Psychiatrica Scandinavica, 96, 85–93.
   PubMed Web of Science ®Google Scholar
• Lader, M. (2011). Benzodiazepines revisited-will we ever learn? Addiction, 106(12), 2086–2109. http://dx.doi.org/10.1111/ j.1360-0443.2011.03563.x.
   PubMed Web of Science ®Google Scholar
• Lagnaoui, R., Depont, F., Fourrier, A., Abouelfath, A., Bégaud, B., Verdoux, H., & Moore, N. (2004). Patterns and correlates of benzodiazepine use in the French general population. European Journal of Clinical Pharmacology, 60(7), 523–529.
   PubMed Web of Science ®Google Scholar
• Mattila-Evenden, M., Bergman, U., & Franck, J. (2001). A study of benzodiazepine users claiming drug-induced psychiatric morbidity. Nordic Journal of Psychiatry, 55(4), 271–278.
   PubMedGoogle Scholar
• Minaya, O., Fresan, A., Cortes-Lopez, J. L., Nanni, R., & Ugalde, O. (2011). The benzodiazepine dependence questionnaire (BDEPQ): validity and reliability in mexican psychiatric patients. Addict Behave, 36(8), 874–877. http://dx.doi. org/10.1016/j.addbeh.2011.03.007.
   PubMedGoogle Scholar
• Pelissolo, A., Boyer, P., Lepine, J. P., & Bisserbe, J. C. (1996). Epidemiology of anxiolytics and hypnotics use in France and in the world. Encephale, 22, 187–196.
   PubMed Web of Science ®Google Scholar
• Pelissolo, A., Maniere, F., Boutges, B, Allouche, M., Richard-Berthe, C., & Corruble, E. (2007). Anxiety and depressive disorders in 4.425 long term benzodiazepine users in general practice. Encephale, 33(1), 32–38.
   PubMed Web of Science ®Google Scholar
• Puangkot, S., Laohasiriwong, W., Saengsuwan, J., & Chiawiriyabunya, I. (2010) Benzodiazepines misuse: the study community level Thailand. Indian Journal of Psychological Medicine, 32(2), 128–130. http://dx.doi.org/10.4103/0253-7176.78510.
   PubMedGoogle Scholar
• Schweizer, E., & Rickels, K. (1998). Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatrica Scandinavica. Supplementum, 393, 95–101.
   PubMedGoogle Scholar
• Tsai, J. H., Tang, T. C., Yeh, Y. C., Yang, Y. H., Yeung, T. H., Wang, S. Y., & Chen, C.C. (2012). The Chinese version of the severity of dependence scale as a screening tool for benzodiazepine dependence in Taiwan. Kaohsiung Journal of Medical Sciences, 28(4), 225–230. http://dx.doi.org/10.1016/j.kjms.2011.06.023.
   PubMedGoogle Scholar
• Urcam île de France (2000). Report. Etude des prescriptions d'anxiolytiques et/ou d'hypnotiques en Ile-De-France. URCAM, 2000/11.
   Google Scholar
• Victorri-Vigneau, C., Dailly, E., Veyrac, G., & Jolliet, P. (2007). Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependance (CEIP) network survey. British Journal of Clinical Pharmacology, 64(2), 198–209. http://dx.doi.org/10.1111/j.1365-2125.2007.02861.x.
   PubMed Web of Science ®Google Scholar
• Victorri-Vigneau, C., & Jolliet, P. (2004). Expertise for the Agence Française de Sécurité Sanitaire des Produits de Santé, personnal communication. Potentiel de pharmacodépendance du zolpidem, enquête de 1993 à 2002.
   Google Scholar
• Vikander, B., Koechling, U. M., Borg, S., Tönne, U., & Hiltunen A. J. (2010). Benzodiazepine tapering: a prospective study. Nordic Journal of Psychiatry, 64(4), 273–282.
   PubMed Web of Science ®Google Scholar
• Voyer, P., Préville, M., Roussel, M. E., Berbiche, D., & Beland, S. G. (2009). Factors associated with benzodiazepine dependence among community-dwelling seniors. Journal of Community Health Nursing, 26(3), 101–113.
   PubMed Web of Science ®Google Scholar
• Voyer, P., Préville, M., Cohen D, Berbiche, D., & Beland, S.G. (2010). The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Canadian Journal on Aging, 29(2), 205–213.
   PubMed Web of Science ®Google Scholar
• Yeh, H. H., Chen, C. Y., Fang, S. Y., Chang, I. S., WU, E. C. H., & Lin, K. M. (2011). Five-year trajectories of long-term benzodiazepine use by adolescents: patient, provider, and medication factors. Psychiatric Services, 62(8), 900–907. http://dx.doi.org/10.1176/appi.ps.62.8.900.
   PubMedGoogle Scholar
• Zanstra, S. M., Furer, J. W., Van de Lisdonk, E. H., Bor, J. H. J., Zitman, F. G., & Van Weel, C. (2002). Difference in health status between long-term and short-term benzodiazepine users. British Journal of General Practice, 52(483), 805–808.
   PubMedGoogle Scholar